Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 559

1.

Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction.

Anand A, Shah ASV, Beshiri A, Jaffe AS, Mills NL.

Clin Chem. 2019 Jan 9. pii: clinchem.2018.298059. doi: 10.1373/clinchem.2018.298059. [Epub ahead of print]

PMID:
30626631
2.

Fourth Universal Definition of Myocardial Infarction (2018).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction.

Circulation. 2018 Nov 13;138(20):e618-e651. doi: 10.1161/CIR.0000000000000617. No abstract available. Erratum in: Circulation. 2018 Nov 13;138(20):e652.

PMID:
30571511
3.

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay.

Muchtar E, Kumar SK, Gertz MA, Grogan M, AbouEzzeddine OF, Jaffe AS, Dispenzieri A.

Blood. 2018 Dec 13. pii: blood-2018-10-875252. doi: 10.1182/blood-2018-10-875252. [Epub ahead of print] No abstract available.

PMID:
30545829
4.

High-Sensitivity Cardiac Troponin I Levels in Normal and Hypertensive Pregnancy.

Ravichandran J, Woon SY, Quek YS, Lim YC, Noor EM, Suresh K, Vigneswaran R, Vasile V, Shah A, Mills NL, Sickan J, Beshiri A, Jaffe AS.

Am J Med. 2018 Nov 30. pii: S0002-9343(18)31140-9. doi: 10.1016/j.amjmed.2018.11.017. [Epub ahead of print]

PMID:
30503877
5.

High-sensitivity cardiac troponin T increases after stress echocardiography.

Samaha E, Brown J, Brown F, Martinez SC, Scott M, Jaffe AS, Davila-Roman VG, Nagele P.

Clin Biochem. 2019 Jan;63:18-23. doi: 10.1016/j.clinbiochem.2018.11.013. Epub 2018 Nov 28.

PMID:
30502318
6.

Between-day versus within-day imprecision using the Abbott high-sensitivity cardiac troponin I assay at concentrations around 5 ng/l.

Kavsak PA, Millar E, McLay G, Clark L, Jaffe AS.

Clin Chim Acta. 2019 Feb;489:58-60. doi: 10.1016/j.cca.2018.11.031. Epub 2018 Nov 28. No abstract available.

PMID:
30502326
7.

Rapid rule-out of suspected acute coronary syndrome in the Emergency Department by high-sensitivity cardiac troponin T levels at presentation.

Fabbri A, Bachetti C, Ottani F, Morelli A, Benazzi B, Spiezia S, Cortigiani M, Dorizzi R, Jaffe AS, Galvani M.

Intern Emerg Med. 2018 Nov 29. doi: 10.1007/s11739-018-1996-6. [Epub ahead of print]

PMID:
30499074
8.

Clinical use of cardiac troponin for acute cardiac care and emerging opportunities in the outpatient setting.

Sandoval Y, Sharain K, Saenger AK, Smith SW, Apple FS, Jaffe AS.

Minerva Med. 2018 Nov 27. doi: 10.23736/S0026-4806.18.05874-3. [Epub ahead of print]

PMID:
30484592
9.

High-Sensitivity Troponin in Patients With Coronary Artery Endothelial Dysfunction.

El Sabbagh A, Prasad M, Zack CJ, Widmer RJ, Karon BS, Lerman A, Jaffe AS.

J Invasive Cardiol. 2018 Nov;30(11):406-410.

10.

[Fourth universal definition of myocardial infarction (2018)].

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL Jr, Apple FS, Alonso Garcia MA, Underwood SR, Canty JM Jr, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS, Newby LK, Virmani R, Vranckx P, Cutlip D, Gibbons RJ, Smith SC, Atar D, Luepker RV, Robertson RM, Bonow RO, Steg PG, O'Gara PT, Fox KAA.

Kardiol Pol. 2018;76(10):1383-1415. doi: 10.5603/KP.2018.0203. Polish. No abstract available.

11.

Evaluation of the Siemens ADVIA Centaur high-sensitivity cardiac troponin I assay in serum.

Kavsak PA, Worster A, Hill SA, Jaffe AS.

Clin Chim Acta. 2018 Dec;487:216-221. doi: 10.1016/j.cca.2018.10.012. Epub 2018 Oct 6.

PMID:
30296440
12.

Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB).

Saenger AK, Jaffe AS, Body R, Collinson PO, Kavsak PA, Lam CSP, Lefèvre G, Omland T, Ordóñez-Llanos J, Pulkki K, Apple FS.

Clin Chem Lab Med. 2018 Oct 6. pii: /j/cclm.ahead-of-print/cclm-2018-0905/cclm-2018-0905.xml. doi: 10.1515/cclm-2018-0905. [Epub ahead of print]

PMID:
30291783
13.

Use of High-Sensitivity Cardiac Troponin in Patients With Chronic Comorbidities: Moving From Theory to Practice.

Jaffe AS, Jaffe HA.

J Am Coll Cardiol. 2018 Sep 4;72(10):1138-1140. doi: 10.1016/j.jacc.2018.06.052. No abstract available.

PMID:
30165985
14.

Fourth universal definition of myocardial infarction (2018).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; ESC Scientific Document Group .

Eur Heart J. 2019 Jan 14;40(3):237-269. doi: 10.1093/eurheartj/ehy462. No abstract available.

PMID:
30165617
15.

Fourth Universal Definition of Myocardial Infarction (2018).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction.

Glob Heart. 2018 Dec;13(4):305-338. doi: 10.1016/j.gheart.2018.08.004. Epub 2018 Aug 25. Review. No abstract available.

PMID:
30154043
16.

Fourth Universal Definition of Myocardial Infarction (2018).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction.

J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25. No abstract available.

PMID:
30153967
17.

Diagnostic concordance between NT-proBNP and BNP for suspected heart failure.

Farnsworth CW, Bailey AL, Jaffe AS, Scott MG.

Clin Biochem. 2018 Sep;59:50-55. doi: 10.1016/j.clinbiochem.2018.07.002. Epub 2018 Jul 6.

PMID:
30111510
18.

1-h High-Sensitivity Troponin Rule-Out and Rule-In Approach: Strengths and Potential Weaknesses.

Alpert JS, Jaffe AS.

J Am Coll Cardiol. 2018 Aug 7;72(6):633-635. doi: 10.1016/j.jacc.2018.05.041. No abstract available. Erratum in: J Am Coll Cardiol. 2018 Sep 18;72(12):1436.

PMID:
30071992
19.

Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery.

Gualandro DM, Puelacher C, LuratiBuse G, Lampart A, Strunz C, Cardozo FA, Yu PC, Jaffe AS, Barac S, Bock L, Badertscher P, du Fay de Lavallaz J, Marbot S, Sazgary L, Bolliger D, Rentsch K, Twerenbold R, Hammerer-Lercher A, Melo ES, Calderaro D, Duarte AJ, de Luccia N, Caramelli B, Mueller C; TropoVasc and BASEL-PMI Investigators.

Am Heart J. 2018 Sep;203:67-73. doi: 10.1016/j.ahj.2018.06.012. Epub 2018 Jul 5.

PMID:
30041065
20.

Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department.

Katzman BM, Lueke AJ, Donato LJ, Jaffe AS, Baumann NA.

Clin Biochem. 2018 Sep;60:11-16. doi: 10.1016/j.clinbiochem.2018.07.004. Epub 2018 Jul 21.

PMID:
30036510
21.

Possible mechanisms behind cardiac troponin elevations.

Hammarsten O, Mair J, Möckel M, Lindahl B, Jaffe AS.

Biomarkers. 2018 Dec;23(8):725-734. doi: 10.1080/1354750X.2018.1490969. Epub 2018 Aug 23.

PMID:
29976112
22.

Plasma Ceramides.

Meeusen JW, Donato LJ, Bryant SC, Baudhuin LM, Berger PB, Jaffe AS.

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1933-1939. doi: 10.1161/ATVBAHA.118.311199.

PMID:
29903731
23.

Analytical performance of an immunoassay to measure proenkephalin.

Donato LJ, Meeusen JW, Lieske JC, Bergmann D, Sparwaßer A, Jaffe AS.

Clin Biochem. 2018 Aug;58:72-77. doi: 10.1016/j.clinbiochem.2018.05.010. Epub 2018 May 18.

PMID:
29782819
24.

Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk: An Observational Study.

Than MP, Aldous SJ, Troughton RW, Pemberton CJ, Richards AM, Frampton CMA, Florkowski CM, George PM, Bailey S, Young JM, Cullen L, Greenslade JH, Parsonage WA, Everett BM, Peacock WF, Jaffe AS, Pickering JW.

Clin Chem. 2018 Jul;64(7):1044-1053. doi: 10.1373/clinchem.2017.285700. Epub 2018 May 14.

PMID:
29760219
25.

Biomarkers Associated with Progression of Diabetic Kidney Disease: Do They Hold the Same Meaning for Blacks and Women?

Hickson LJ, Balls-Berry JE, Jaffe AS, Rule AD.

J Am Soc Nephrol. 2018 Jun;29(6):1781. doi: 10.1681/ASN.2017121249. Epub 2018 Apr 20. No abstract available.

PMID:
29678999
26.

Science Moves Slowly.

Jaffe AS, Apple FS.

J Am Coll Cardiol. 2018 Apr 10;71(14):1550-1552. doi: 10.1016/j.jacc.2018.01.068. No abstract available.

PMID:
29622162
27.

Clarifying the Proper Definitions for Type 2 Myocardial Infarction.

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, White HD.

J Am Coll Cardiol. 2018 Mar 20;71(11):1291. doi: 10.1016/j.jacc.2017.12.063. No abstract available.

PMID:
29544614
28.

The prognostic impact of periprocedural myocardial infarction and injury.

Thygesen K, Jaffe AS.

Eur Heart J. 2018 Apr 1;39(13):1110-1112. doi: 10.1093/eurheartj/ehy089. No abstract available.

PMID:
29529182
29.

High-sensitivity cardiac troponin T in young, healthy adults undergoing non-cardiac surgery.

Duma A, Wagner C, Titz M, Maleczek M, Hüpfl M, Weihs VB, Samaha E, Herkner H, Szekeres T, Mittlboeck M, Scott MG, Jaffe AS, Nagele P.

Br J Anaesth. 2018 Feb;120(2):291-298. doi: 10.1016/j.bja.2017.09.001. Epub 2017 Dec 5.

PMID:
29406178
31.

Meta-Analyses and Interpretation of Troponin Values in Heart Failure.

Jaffe AS, Miller WL.

JACC Heart Fail. 2018 Mar;6(3):198-200. doi: 10.1016/j.jchf.2017.12.001. Epub 2018 Jan 10. No abstract available.

PMID:
29331273
32.

Comparing analytical outliers and the percent of emergency department patients with results above the 99th percentile upper reference limit for 2 conventional and one high sensitivity troponin assay.

Karon BS, Wockenfus AM, Hartung KJ, Scott RJ, Carter SD, Jaffe AS.

Clin Biochem. 2018 Mar;53:104-109. doi: 10.1016/j.clinbiochem.2018.01.001. Epub 2018 Jan 2.

PMID:
29305092
33.

Variability Between Reagent Lots for High-Sensitivity Cardiac Troponin I May Affect Performance of Early Rule Out Strategies.

Kavsak PA, Worster A, Oliver R, Clark L, Parry D, Randell E, Sarfaraz MO, Hill S, Jaffe AS.

Can J Cardiol. 2018 Feb;34(2):209.e5-209.e6. doi: 10.1016/j.cjca.2017.11.010. Epub 2017 Nov 22. No abstract available.

PMID:
29287942
34.

How is cardiac troponin released from injured myocardium?

Mair J, Lindahl B, Hammarsten O, Müller C, Giannitsis E, Huber K, Möckel M, Plebani M, Thygesen K, Jaffe AS.

Eur Heart J Acute Cardiovasc Care. 2018 Sep;7(6):553-560. doi: 10.1177/2048872617748553. Epub 2017 Dec 27. Review.

PMID:
29278915
35.

Significance of High-Sensitivity Troponin T After Elective External Direct Current Cardioversion for Atrial Fibrillation or Atrial Flutter.

Lobo R, Jaffe AS, Cahill C, Blake O, Abbas S, Meany TB, Hennessy T, Kiernan TJ.

Am J Cardiol. 2018 Jan 15;121(2):188-192. doi: 10.1016/j.amjcard.2017.10.009. Epub 2017 Oct 19.

PMID:
29221605
36.

Are high-sensitivity cardiac troponin I values stable between preoperative visit and day of non-cardiac surgery?

Samaha E, Helwani MA, Brown JC, Brown F, Jaffe AS, Scott MG, Nagele P.

Clin Biochem. 2018 Feb;52:171-172. doi: 10.1016/j.clinbiochem.2017.11.014. Epub 2017 Nov 22.

PMID:
29175409
37.

Reply to letter by Trupp et al.

Apple FS, Saenger AK, Gunsolus IL, Love SA, Jaffe AS.

Clin Biochem. 2018 Feb;52:174. doi: 10.1016/j.clinbiochem.2017.11.012. Epub 2017 Nov 21. No abstract available.

PMID:
29162471
38.

ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway.

Than MP, Pickering JW, Dryden JM, Lord SJ, Aitken SA, Aldous SJ, Allan KE, Ardagh MW, Bonning JWN, Callender R, Chapman LRE, Christiansen JP, Cromhout APJ, Cullen L, Deely JM, Devlin GP, Ferrier KA, Florkowski CM, Frampton CMA, George PM, Hamilton GJ, Jaffe AS, Kerr AJ, Larkin GL, Makower RM, Matthews TJE, Parsonage WA, Peacock WF, Peckler BF, van Pelt NC, Poynton L, Richards AM, Scott AG, Simmonds MB, Smyth D, Thomas OP, To ACY, Du Toit SA, Troughton RW, Yates KM; ICare-ACS Implementation Group.

Circulation. 2018 Jan 23;137(4):354-363. doi: 10.1161/CIRCULATIONAHA.117.031984. Epub 2017 Nov 14.

PMID:
29138293
39.

Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity-2.

Gerber Y, Weston SA, Enriquez-Sarano M, Jaffe AS, Manemann SM, Jiang R, Roger VL.

J Am Heart Assoc. 2017 Oct 20;6(10). pii: e005958. doi: 10.1161/JAHA.117.005958.

40.

Safety of magnetic resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads.

Padmanabhan D, Kella DK, Mehta R, Kapa S, Deshmukh A, Mulpuru S, Jaffe AS, Felmlee JP, Jondal ML, Dalzell CM, Asirvatham SJ, Cha YM, Watson RE Jr, Friedman PA.

Heart Rhythm. 2018 Feb;15(2):228-233. doi: 10.1016/j.hrthm.2017.10.022. Epub 2017 Oct 16.

PMID:
29045806
41.

Detecting myocardial infarction type 2: targetting the right patients.

Thygesen K, Jaffe AS.

Eur Heart J. 2017 Dec 14;38(47):3521-3522. doi: 10.1093/eurheartj/ehx557. No abstract available.

PMID:
29029142
42.

Improving the Specificity of Cardiac Biomarkers-The Early Development of Cardiac Troponin I (cTnI) Assays.

Jaffe AS.

Clin Chem. 2018 Mar;64(3):609-610. doi: 10.1373/clinchem.2017.272906. Epub 2017 Oct 11. Review. No abstract available.

PMID:
29021328
43.

Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10years.

Kavsak PA, Worster A, Hill SA, MacRae AR, Jaffe AS.

Clin Chim Acta. 2017 Dec;475:51-55. doi: 10.1016/j.cca.2017.10.006. Epub 2017 Oct 7.

PMID:
29017768
44.

Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits.

Gunsolus IL, Jaffe AS, Sexter A, Schulz K, Ler R, Lindgren B, Saenger AK, Love SA, Apple FS.

Clin Biochem. 2017 Dec;50(18):1073-1077. doi: 10.1016/j.clinbiochem.2017.09.009. Epub 2017 Sep 13.

PMID:
28916437
45.

Role of Admission Troponin-T and Serial Troponin-T Testing in Predicting Outcomes in Severe Sepsis and Septic Shock.

Vallabhajosyula S, Sakhuja A, Geske JB, Kumar M, Poterucha JT, Kashyap R, Kashani K, Jaffe AS, Jentzer JC.

J Am Heart Assoc. 2017 Sep 9;6(9). pii: e005930. doi: 10.1161/JAHA.117.005930.

46.

Using High-Sensitivity Cardiac Troponin T for Acute Cardiac Care.

Sandoval Y, Jaffe AS.

Am J Med. 2017 Dec;130(12):1358-1365.e1. doi: 10.1016/j.amjmed.2017.07.033. Epub 2017 Aug 23.

PMID:
28843652
47.

High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes.

Vasile VC, Jaffe AS.

Curr Cardiol Rep. 2017 Aug 24;19(10):92. doi: 10.1007/s11886-017-0904-4. Review.

PMID:
28840515
48.

Renal Dysfunction: How to Think About That in Acute Coronary Syndromes.

Babuin L, Scarpa D, Jaffe AS.

Curr Cardiol Rep. 2017 Aug 24;19(10):91. doi: 10.1007/s11886-017-0903-5. Review.

PMID:
28840463
49.

Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method.

Whelton SP, Meeusen JW, Donato LJ, Jaffe AS, Saenger A, Sokoll LJ, Blumenthal RS, Jones SR, Martin SS.

J Clin Lipidol. 2017 Jul - Aug;11(4):1065-1072. doi: 10.1016/j.jacl.2017.05.005. Epub 2017 Jun 1.

PMID:
28826567
50.

Eliminating Creatine Kinase-Myocardial Band Testing in Suspected Acute Coronary Syndrome: A Value-Based Quality Improvement.

Alvin MD, Jaffe AS, Ziegelstein RC, Trost JC.

JAMA Intern Med. 2017 Oct 1;177(10):1508-1512. doi: 10.1001/jamainternmed.2017.3597. Review. Erratum in: JAMA Intern Med. 2017 Oct 1;177(10):1544.

PMID:
28806444

Supplemental Content

Loading ...
Support Center